Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
| Príomhchruthaitheoirí: | , , |
|---|---|
| Formáid: | Conference item |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
American Heart Association
2022
|
| Achoimre: |
|---|